Insulin-like growth factor-1 (IGF-1) is an essential anabolic growth factor in the regulation of cartilage metabolism and exerts its effects by binding to the IGF-1 Type 1 receptor on the chondrocyte membrane. We have localized and quantified in situ IGF-1 receptor expression in intact articular cartilage of normal mice. The IGF-1 receptor was detected immunohistochemically with antibodies to the IGF-1 receptor and visualized with conventional light microscopy and confocal laser scanning miaoscopy (CLSM). CLSM analysis enabled us to distinguish IGF-1 receptor immunoreactivity on the chondrocyte cell membrane from intracellular staining. We have established two approaches to quantitir in confocal images low levels of fluorescence intensity of the immuno-
Introduction
Articular cartilage consists of proteoglycans (PGs) attached to the collagen network of the extracellular matrix. Chondrocytes are embedded in the extracellular matrix and regulate the continuous tumover of PGs within the matrix. Control of chondrocyte biosynthetic function is essential in maintaining the integrity of articular cartilage. Both systemic and locally produced growth factors are known to regulate cartilage metabolism (10).
Insulin-like growth factor-1 (IGF1) is the most important growth factor that regulates PG synthesis in human, bovine, and murine chondrocytes (9,16,18,31). Sex hormones and growth hormone are known to influence the IGFl plasma and tissue levels, although in a previous study it has been reported that for sexually mature male or female animals, IGF-1 responses of cartilage metabolism are relatively the same (14,38). IGFl initiates its biological response by high-affinity binding to specific receptors localized on the chondrocyte plasma membrane, such as the IGF-1 Type 1 and Type 2 Supported by the TNO. localized IGF-1 receptor at the chondrocyte membrane, i.e., mean pixel measurement and area measurement. The majority of IGF-1 receptor fluorescence intensity was localized on chondrocytes in the middle and deeper zones of cartilage, whereas chondrocytes in the surface zone exhibited negligible fluorescence. The variable distribution of IGF-1 receptor in chondrocytes of articular cartilage suggests that effects of IGM on chondrocytes may be distinctly heterogeneous in the different mouse articular cartilage zones. ( J fiktochem Cytochem &:765-773, 15%) receptors (7,15, 21, 22) . The type 1 receptor binds IGFl with higher affinity than the Type 2 receptor. The Type 2 receptor regulates chondrocyte PG synthesis during embryological development, whereas the Type 1 receptor mainly controls PG synthesis of adult cartilage (15). This IGFl Type 1 receptor is a transmembrane glycoprotein, consisting of two a-and P-subunits that are coupled by disulfide bridges and linked in an a 2 8 2 heterotetrameric configuration. The extracellular a-subunits are involved in ligand binding, whereas the P-subunits traverse the cell membrane and contain a tyrosine kinase domain in their cytoplasmic region (26,37).
Specific binding of IGFl to the IGFl Type 1 receptor has been demonstrated in human and animal growth plate chondrocytes with competitive binding studies (5,33,36). Moreover, the IGFl Type 1 receptor has been identified immunohistochemically on human intact articular cartilage (19) . However, it is not yet known whether chondrocytes in the different articular cartilage zones express heterogeneously different amounts of receptor, although these zones display differences in metabolic activity (2-4,17,30,34).
The aim of the present study was to investigate in situ IGFl receptor expression by examining chondrocytes in the different zones of intact murine articular cartilage. To this end, the IGF-1 receptor was detected by immunofluorescence in cryostat sections of intact normal mouse patella with antibodies against the a-subunit of the IGF-1 receptor (13, 23, 28, 29, 35) . We examined mouse patellar cartilage because in previous studies much information has been gained about the chondrocyte metabolism of the intact mouse patella (41).
In addition to conventional fluorescence microscopy, confocal laser scanning microscopy (CLSM) was used to determine the in situ IGFl receptor expression in intact cartilage. The CUM collects images that are almost free of out-of-focus signals, which results in improved spatial resolution compared with conventional microscopy (46-48). Moreover, CLSM allows optical sectioning of the specimen and three-dimensional (3D) reconstruction of the microscopic object. Therefore, CLSM provides the tools of choice for image analysis to accurately localize and quantify IGF-l receptor expression in articular cartilage.
Materials and Methods

Animals
Sexually mature female C57 blackl6 mice (8-12 weeks old, 20-25 g) were used. The animals were kept under routine laboratory conditions (21-22' C, relative humidity 60%. 12-hr light1dark cyde). The mice were fed a standard commercial pellet diet (RHM; Hope Farms, The Netherlands) and were given acidified tapwater ad libitum.
Preparation of Tissues
The mice were sacrificed by cervical dislocation and whole patellae were dissected from the knee joints. The patellar ligaments were cut, leaving the cartilage fully intact (41). The patellae were embedded in an aqueous gelatin solution of 8% gelatin white (Sigma; St Louis, MO), frozen in liquid nitrogen, and kept at -8O'C until sectioning (1).
Preparation of Cryostat Sections
Sections of fresh-frozen, undecalcified mouse patellae were cut (7 pm thick) in the sagittal plane on a motor-driven Bright cryostat fitted with a microtome with a tungsten carbide-tipped knife at a cabinet temperature of -25'C (11,24) and were attached to adhesive tape (Scotch tape 800) (3M; St Paul, MN) (27, 42, 45) . Sections were kept over silica gel and stored at -25'C until further use.
Immunohistochemistry
Immunoperoxidase Method. Sections were briefly fixed in acetone (analytical grade) (Merck; Darmstadt, Germany) for 7 sec and air-dried (6,45). Then they were incubated for 30 min at 37'C in a solution of 2 mglml testicular hyaluronidase (Sigma) diluted in PBS to obtain better antibody penetration into the cartilage matrix. The slides were rinsed with PBS and finally treated with 10% fetal calf serum and 1% BSA in PBS for 30 min to block aspecific binding. Thereafter, the sections were incubated for 24 hr at 4% with primary antibodies, i.e., biotinylated mouse monoclonal antibody (MAb) or rabbit polyclonal antibody, both in a concentration of 5 pglml in PBS in the presence of 1% BSA. At this concentration the immunoreactivity signal was saturated. The mouse MAb aIR-3, which recognizes human Type 1 IGF-1 receptor, was obtained from Oncogene Science (Manhasset, NY) (13.28.35) . The polydonal rabbit anti-humanType 1 IGFl receptor was obtained from UBI (New York, NY) (23, 29) . Both antibodies show crossreactivity with mouse Type 1 IGF-1 receptor. After incubation with the primary antibodies, the slides were washed three times in PBS. Sections incubated with rabbit polydonal antibody were subjected to a three-step immunostaining procedure, i.e.. incubated with biotinylated goat antirabbit secondary antibody (Vector Laboratories; Burlingame, CA) for 1 hr at a dilution of 1500 in PBS in the presence of 1% BSA and 1% normal mouse serum, washed three times in PBS. and exposed to streptavidin-peroxidase conjugate (Boehringer; Mannheim, Germany) diluted 1:lOoO in PBS for 30 min. Sections incubated with'the biotinylated anti-IGF1 receptor MAb were used in a two-step immunostaining procedure, i.e., incubated with streptavidin-peroxidase conjugate. After washing in PBS, peroxidase activity was demonstrated by incubation for 10 min with 0.5 mg1ml 3,3'diaminobenzidine-tetrahydrochloride (DAB) (Sigma) dissolved in 1 ml 0.05 M Tris-HC1 buffer, pH 7.6, containing 0.02% H202. The sections were counterstained with Mayer's hematoxylin and embedded in gelatin-glycerin. LM evaluation of the slides was performed with a Leitz microscope. Control sections were incubated with either an IgG fraction of normal rabbit serum or biotinylated mouse IgGl, both used in the same dilution as the primary antibody, or in the absence of primary antibody.
Immunofluorescence Method. The cryostat sections were fixed for 10 min in 4% paraformaldehyde (Sigma), diluted in PBS, pH 7.4, and subsequently washed in PBS containing 10% BSA (Sigma), 10% gelatin, and 0.3% glycine (Pharmacia; Uppsala, Sweden). All further incubations were performed as described above. Thereafter, the slides were exposed to streptavidin-FIE (Boehringer) in a concentration of 5 pglml in PBS. Subsequently, the slides were mounted in glycerol-phenylenediamine solution (Sigma) to avoid fading of the fluorescence. The slides were kept at -25 'C until evaluation with the CUM.
Fluorescence CLSM and Image Analysis
Sections were examined with a Leica CUM fitted to a Leica Fluovert microscope, equipped with a PL APO 6311.40 oil-immersion objective. Chondrocytes situated in the different zones of the cartilage (deep, middle, and surface zones) were randomly selected with the use of a raster. For excitation of FITC, the 488-nm line of an argon-krypton laser was used, fitted with a 510-nm dichroic mirror and a 530-nm bandpass filter. The pinhole aperture was set at 100, giving an optimized image (48). With fixed pinhole, filter combination, and a laser power setting adjusted to give minimal fa*, the photomultiplier gain and photometric offset were optimized. These settings were rigorously maintained within each experiment. Immunolabeled cryostat sections were subjected to optically serial sectioning offering images in the X-Y plane. Images of optical sections were recorded with intervals of 0.5 pm in the Z direction. For analysis, each optical section was averaged eight times. Images were recorded in a 512 x 512 pixel format. The size of each pixel represented 0.015 pm2 in the object.
For quantification, the largest optical cross-section of each chondrocyte was selected and stored on optical disc for subsequent display and analysis, using standard Leica CUM instrument software. Quantification of the immunofluorescence signal indicating IGFl receptor expression was performed in two ways. One approach was point measurement by determining fluorescence intensity of eight pixels evenly distributed at the chondrocyte periphery. The mean fluorescence intensity in these pixels represented the immunoreactivity obtained from in situ detection of the IGF-1 receptor.
To assess the contribution of autofluorescence and aspecific binding, the fluorescence signal in sections stained with control non-immune serum was measured as well. The second approach was area measurement by determination of fluorescence intensity of the chondrocyte periphery by manually setting a window over the chondrocyte periphery. The CLSM instrument software provides the averaged intensity (ji1 pm2) as found in the window. The distance between the outer rims of these two windows was kept at m0.2 pm. Again, nonspecific fluorescence was determined in control sections.
In each cartilage zone. the fluorescence intensity was measured in 10 chondrocytes in each of two serial sections. The chondrocytes were randomly selected in horizontal direction with the use of a microscopic eyepiece grid.
The average fluorescence intensity o f 10 chondrocytes was expressed as the percentage of che highen value measured in each cartilage zone. Data represent ehc mean * SEM offour independent experiments. Sratiscical cvaluarion of the experiments was performed with the Wilcoxon rank test. A p value of less than 5% was considered significant.
Results
Immunohistochemical Localization of IGFl Receptor
LM evaluation of immunoperoxidase and immunofluorescence staining of cartilage sections rcvcalcd that the fluorescence staining was more sensitive for detection of IGFl receptor than the peroxidase staining. Howcvcr. fluorescence-stained sections showed a veil of green autofluorescence that obscured the view somewhat. Chondrocytes within the articular cartilage showed the presence of IGFl receptor. whereas the cartilage matrix remained negative (Figures 1A-IC). Immunoreactivity was not restricted to the chondrocyte cell surface but a diffuse intracellularstaining was observed as well.
Immunostaining of the IGFl receptor with the mouse MAb aIR-3 resulted in a rather dot-like staining pattern. mainly at the chondrocyte membrane. as shown in Figure 1B . Incubation with rabbit polyclonal anti-IGF-1 receptor resulted in a more homogeneous staining pattern at the chondrocyte membrane and intracellularly ( Figure 1A ). Sections treated with either non-immune rabbit serum or biotinylated mouse IgG showed a low proportion of background staining. Figure IC shows background staining after treatment with biotinylated mouse IgG. At the LM lcvcl it was difficult to determine exactly the amount of in situ IGFl receptor immunoreactivity on the Chondrocyte plasma membrane. Figure 2 shows consecutive optical sections of a chondrocyte taken at intervals of 0.5 vm. The images demonstrated enhanced spatial resolution of the localized receptor as detected with immunofluorescence compared with LM evaluation. For further CUM analysis, the polyclonal antibody was used. The chondrocyte membrane showed lGF1 receptor immunoreactivity, but intracellularly. chondrocytes displayed a rather granular fluorescence staining as wcll. A considerable amount of background fluorescence due to aspecific binding, as well as autofluorescence, was often observed along the cartilage surface edge. as shown in Figure 3 . Use of the anti-fading agent phenylenediamine largely prevented fading of the fluorescence caused by laser light excitation. Even after accumulation and averaging of eight scans, no attenuation of fluorescence signal was noted.
CUM Analysis
CLSM analysis revealed that IGFl receptor staining at the chondrocyte cell surface was particularly found in chondrocytes of the middle cartilage zone (Figure 3 ). The cells showed bright positive staining at the chondrocyte periphery ( Figure 4A ). Chondrocytes located in the deeper zones exhibited distinct heterogeneity of cell surface staining ( Figure 4B ). Chondrocytes in the surface zone displayed apparently less bright staining (Figure 4D ).
Quuntz3cution of IGF-1 Receptor Expression
Quantification of the immunofluorescence intensity in the confocal images was performed in two ways, as described in Materials and Methods. Following the first approach, the mean fluorescence intensity at the periphery of randomly selected chondrocytes located in each of the three cartilage zones was similar for either mouse MAb or rabbit polyclonal anti-IGF-1 receptor antibody. The fluorescence intensity as determined by mean pixel measurement on the chondrocyte membrane in surface, middle, or deeper zones of cartilage yielded values of 57 2 16, 100 e 17, and 78 -c 19, respectively (Table 1 ). Fluorescence as determined by area measurement revealed that similar results were obtained as with mean pixel measurement, as shown in Table l and Figure 5 . Quantification of the nonspecific fluorescence intensity showed a constant background in all cartilage layers, with no significant variation between the independent experiments of either point or area measurement (Fig-ure 5) . The fluorescence intensity level in chondrocytes in the surface zone was similar to the nonspecific fluorescence intensity.
Both quantification methods clearly demonstrated that the fluorescence intensity of chondrocytes located in middle or deeper zones of the cartilage was significantly higher than that of chondrocytes located in the surface zone. The fluorescence signal ofchondrocytes in the surface zone was similar to background fluorescence intensity, whereas chondrocytes in the middle zone exhibited highest fluorescence intensity. Chondrocytes in the deeper zones showed a mean specific fluorescence intensity ~~5 0 % lower than that of cells in the middle zone, although area measurement yielded a somewhat higher signal in chondrocytes of the deeper layers than point measurements. However, no significant difference appeared.
Discussion
IGF-I plays a key role in the regulation of chondrocyte biosynthetic function (9,16.18,31) . IGFl initiates its biological response by binding to a specific receptor, the IGFl Type 1 or Type 2 receptor (7, 21) . In the present study, we have analyzed IGFl Type 1 receptor expression in situ in patellar cartilage of sexually mature female mice, because in adult cartilage binding to the IGF-I Type 1 receptor is known to be of utmost metabolic importance (15). Immunostaining and confocal laser scanning microscopy were used to localize and quantify receptor expression.
We demonstrated the localization of the IGFl receptor in articular cartilage chondrocytes. The two types of IGFl receptor antibodies used to detect IGF-1 receptor expression displayed different staining patterns. This implies either that the antibodies do not recognize exactly the same epitopes of the a-subunit of the IGF-1 receptor or that the antibodies react differently after the fixation procedures used. Investigations at the LM level of receptor expression after immunoperoxidase staining showed immunoreactivity on the chondrocyte cell surface as well as intracellular staining. Therefore, immunoperoxidase staining of the IGFl receptor did not allow accurate examination of receptor immunoreactivity on the chondrocyte membrane. On the other hand, CUM optical sectioning of the specimen demonstrated improved localization of the IGFl receptor by eliminating glare from structures above or below the focus plane (46.47). The method applied in the present study to measure the fluorescence intensity of CLSM images from the immunolocalized IGFl receptor in the chondrocyte periphery enabled us to distinguish membrane staining from intracellular staining. It remains undecided what is represented by the intracellular staining, but it is likely that it is internalized and/or newly synthesized IGFl receptor. The amount of intracellular receptor, in comparison with the amount present on the chondrocyte membrane, could give valuable information about the regulation of chondrocyte biosynthetic activity under various physiological or pathophysiological conditions, such as growth and joint inflammation. The quantitative histochemical method using CLSM to differentiate between membrane and intracellular compartments is an excellent tool to study metabolic dynamics.
The present study demonstrates that the application of CLSM is advantageous to study in situ receptor immunolocalization on intact cartilage tissue, where discrimination against background staining is a serious problem. It should be noted that chondrocytes contain only a low level of IGFl receptors. Moreover, we studied cryostat sections of intact cartilage, in which the amount of receptors detected on chondrocytes may be even less than the amount of receptors in isolated chondrocytes. Wonon et al. (49) described the advantage and versatility of using confocal microscopy in conjunction with immunofluorescent localization, but did not describe the use of CLSM in quantlfying the immunolocalized fluorescence signal. Good et al. (8) described a method to quantify binding of a fluorescence-labeled growth factor to its receptor on single cells in situ using confocal microscopy. Other aspects of quantitative immunohistochemical detection by CLSM have been described (e.g., 8,20,25,43) . Our study describes a fast, specific approach to analyze and quantify in situ immunohistochemically localized IGF-1 receptor on intact tissue sections. Two approaches were performed to quantlfy the fluorescence signal from confocal images, i.e., point measurement and area measurement. In general, both methods yielded comparable and reproducible results, demonstrating the validity of the quantitative approach. The amount of background fluorescence as quantified in the different cartilage layers with both methods (Table 1) was relatively high compared with the total fluorescence signal, but this is an inherent problem of low levels of antigen.
The use of a CUM was essential to study the immunohistochemically localized IGFl receptor in different zones of the cartilage. CLSM analysis revealed that the majority of labeling was localized on chondrocytes in the middle and deep zones of the cartilage, whereas fluorescence intensity of chondrocytes in the surface zone was indistinguishable from background fluorescence. In human, pig, and bovine cartilage, it is known from either investigations of the metabolic functions of isolated chondrocytes from different zones of the cartilage or in situ autoradiography that chondrocytes in the different zones vary in their metabolic state (2) (3) (4) 17, 34) . Hmever, in mouse cartilage these findings have not been confirmed as yet. Our findings show that IGFl receptor immunoreactivity is not homogeneously distributed throughout the different cartilage zones. It can be suggested that.IGF1 receptor expression in the different cartilage layers reflects heterogeneity in IGFl stimulation and activity of the chondrocytes in these layers. We have demonstrated previously that in contrast to the ability of IGFl to sustain chondrocyte PG synthesis of normal murine articular cartilage during culture (31), chondrocytes from experimentally induced arthritic knee joints do not respond to IGFl(4). During arthritis, suppressive mediators such as interleukin-1 (ILl) and tumor necrosis factor (TNF) are produced by the inflamed synovium and are potent inhibitors of chondrocyte metabolism (39, 40, 44) . It remains a matter of speculation whether inflammatory mediators are involved in the nonresponsive state to IGFl stimulation during experimentally induced arthritis. CUM analysis of IGFl receptor expression in cartilage during different stages of arthritis has been recently investigated (Verschure et al., manuscript in preparation) .
In conclusion, we have used immunohistochemistry, light microscopy, and confocal laser scanning microscopy to visualize and quantlfy in situ IGFl receptor expression in mouse articular cartilage. Using CUM, IGFl receptor immunoreactivity on the chondrocyte membrane could be distinguished from intracellular staining. CUM analysis confirmed the visual interpretation with conventional light microscopy. However, CUM enabled Us to quantky chondrocyte membrane receptor expression in chondrocytes located in the different zones of the cartilage. 
